𝔖 Bobbio Scriptorium
✦   LIBER   ✦

From basic research to clinical development of MEK1/2 inhibitors for cancer therapy

✍ Scribed by Christophe Frémin; Sylvain Meloche

Book ID
115025381
Publisher
BioMed Central
Year
2010
Tongue
English
Weight
1009 KB
Volume
3
Category
Article
ISSN
1756-8722

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Target molecules for anti-angiogenic the
Target molecules for anti-angiogenic therapy: from basic research to clinical trials
✍ Martin Hagedorn; Andreas Bikfalvi 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 280 KB

There is growing evidence that anti-angiogenic drugs will improve future therapies of diseases like cancer, rheumatoid arthritis and ocular neovascularisation. However, it is still uncertain which kind of substance, out of the large number of angiogenesis inhibitors, will prove to be a suitable agen

Drug Delivery in Oncology (From Basic Re
Drug Delivery in Oncology (From Basic Research to Cancer Therapy) || Development of Cancer-Targeting Ligands and Ligand-Drug Conjugates
✍ Kratz, Felix; Senter, Peter; Steinhagen, Henning 📂 Article 📅 2011 🏛 Wiley-VCH Verlag GmbH & Co. KGaA 🌐 German ⚖ 312 KB

In This First Authoritative Overview On Modern Cancer Chemotherapy 121 International Specialists Have Contributed Their Experience And Recent Data For What Is Likely To Become The Gold Standard In The Field. The Authors Summarize Knowledge Gained Over The Past Decade, From Basic Concepts To Successf